These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3134122)

  • 21. Lack of initiating capacity of the genotoxic air pollutant 2-nitrofluorene in the mouse skin two-stage carcinogenesis system.
    Möller L; Zeisig M; Toftgård R
    Carcinogenesis; 1993 Aug; 14(8):1723-5. PubMed ID: 8353860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
    Reiners JJ; Singh KP
    Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of dose of initiator on two-stage skin carcinogenesis in BALB/c mice with cellular mosaicism.
    Reddy AL; Fialkow PJ
    Carcinogenesis; 1988 May; 9(5):751-4. PubMed ID: 3130203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
    Birt DF; Pelling JC; Tibbels MG; Schweickert L
    Nutr Cancer; 1989; 12(2):161-8. PubMed ID: 2496398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide.
    Hennings H; Shores R; Balaschak M; Yuspa SH
    Cancer Res; 1990 Feb; 50(3):653-7. PubMed ID: 2105160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
    Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
    Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin.
    Mitchel RE; Morrison DP; Gragtmans NJ
    Carcinogenesis; 1988 Mar; 9(3):379-85. PubMed ID: 3125992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-trans retinoic acid protects against conversion of chemically induced and ultraviolet B radiation-induced skin papillomas to carcinomas.
    Athar M; Agarwal R; Wang ZY; Lloyd JR; Bickers DR; Mukhtar H
    Carcinogenesis; 1991 Dec; 12(12):2325-9. PubMed ID: 1747935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse.
    Birt DF; White LT; Choi B; Pelling JC
    Cancer Res; 1989 Aug; 49(15):4170-4. PubMed ID: 2472874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOCA and some proposed substitutes (Cyanacure, Conacure, Polacure 740M and Ethacure 300) as two-stage skin carcinogens in HRA/Skh hairless mice.
    Rozinova E; Khalil M; Bonin AM
    Mutat Res; 1998 Feb; 398(1-2):111-21. PubMed ID: 9626971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
    Ordman AB; Cleaveland JS; Boutwell RK
    Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoylphorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice.
    Ward JM; Rehm S; Devor D; Hennings H; Wenk ML
    Environ Health Perspect; 1986 Sep; 68():61-8. PubMed ID: 3096710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.
    Wei H; Tye L; Bresnick E; Birt DF
    Cancer Res; 1990 Feb; 50(3):499-502. PubMed ID: 2105157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ; Pavone A; Rupp T; Cantu AR
    Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
    Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion.
    Birt DF; Pelling JC; Anderson J; Barnett T
    Carcinogenesis; 1994 Oct; 15(10):2341-5. PubMed ID: 7955075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice.
    Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH
    Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.